Athene Stock Forecast, Price & News

Athene (NYSE:ATH) Frequently Asked Questions

Is Athene a buy right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Athene in the last year. There are currently 12 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Athene stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ATH, but not buy additional shares or sell existing shares.
View analyst ratings for Athene or view top-rated stocks.

How has Athene's stock been impacted by Coronavirus (COVID-19)?

Athene's stock was trading at $31.16 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ATH stock has increased by 170.4% and is now trading at $84.25.
View which stocks have been most impacted by COVID-19.

Are investors shorting Athene?

Athene saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 4,180,000 shares, a drop of 20.8% from the October 31st total of 5,280,000 shares. Based on an average daily trading volume, of 1,030,000 shares, the days-to-cover ratio is currently 4.1 days. Approximately 3.2% of the shares of the stock are sold short.
View Athene's Short Interest.

When is Athene's next earnings date?

Athene is scheduled to release its next quarterly earnings announcement on Wednesday, February 16th 2022.
View our earnings forecast for Athene.

How were Athene's earnings last quarter?

Athene Holding Ltd. (NYSE:ATH) announced its quarterly earnings results on Wednesday, November, 3rd. The insurance provider reported $2.73 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.10 by $0.63. The insurance provider earned $1.47 billion during the quarter, compared to analyst estimates of $1.57 billion. Athene had a net margin of 13.69% and a trailing twelve-month return on equity of 14.35%. The company's revenue was up 21.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.53 earnings per share.
View Athene's earnings history.

What price target have analysts set for ATH?

13 brokerages have issued 1 year target prices for Athene's stock. Their forecasts range from $50.00 to $89.00. On average, they anticipate Athene's share price to reach $71.89 in the next twelve months. This suggests that the stock has a possible downside of 14.7%.
View analysts' price targets for Athene or view top-rated stocks among Wall Street analysts.

Who are Athene's key executives?

Athene's management team includes the following people:

• James R. Belardi, Chairman, Chief Executive & Investment Officer
• Bill Wheeler, President
• Marty Klein, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
• Randy Epright, Chief Information Officer & Executive VP
• Michael S. Downing, Executive Vice President & Chief Actuary

Who are some of Athene's key competitors?

Some companies that are related to Athene include MetLife (MET), Prudential (PUK), China Life Insurance (LFC), Prudential Financial (PRU), Manulife Financial (MFC), Sun Life Financial (SLF), Swiss Re (SSREY), Aviva (AVVIY), Legal & General Group (LGEN), Lincoln National (LNC), Aegon (AEG), Sony Financial (SNYFY), Globe Life (GL), Voya Financial (VOYA) and Reinsurance Group of America (RGA).
View all of ATH's competitors.

What other stocks do shareholders of Athene own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Athene investors own include DocuSign (DOCU), AT&T (T), Alibaba Group (BABA), Intel (INTC), Applied Materials (AMAT), JD.com (JD), Okta (OKTA), Visa (V), Slack Technologies (WORK) and AbbVie (ABBV).

When did Athene IPO?

(ATH) raised $952 million in an IPO on Friday, December 9th 2016. The company issued 23,800,000 shares at a price of $38.00-$42.00 per share. Goldman Sachs, Barclays, Citigroup and Wells Fargo Securities served as the underwriters for the IPO and BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, BNP PARIBAS, BTIG, Evercore ISI, SunTrust Robinson Humphrey, UBS Investment Bank, Apollo Global Securities, Dowling & Partners Securities, Keefe, Bruyette & Woods (A Stifel Company), Lazard, Raymond James, Rothschild, Sandler O’Neill + Partners and The Williams Capital Group, L.P. were co-managers.

What is Athene's stock symbol?

Athene trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATH."

Who are Athene's major shareholders?

Athene's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (3.67%), Wellington Management Group LLP (2.54%), Dimensional Fund Advisors LP (2.11%), Neuberger Berman Group LLC (1.62%), Goldman Sachs Group Inc. (1.59%) and Invesco Ltd. (1.40%). Company insiders that own Athene stock include Grant Kvalheim, H Carl Mccall, James Richard Belardi, John Leonard Golden, Lawrence Ruisi, Marc A Beilinson, Marc J Rowan, Marc J Rowan, Marc Ostryniec, Martin P Klein, Robert L Borden and Robert L Borden.
View institutional ownership trends for Athene.

Which major investors are selling Athene stock?

ATH stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Two Sigma Advisers LP, Two Sigma Investments LP, Arrowstreet Capital Limited Partnership, Phoenix Holdings Ltd., CI Investments Inc., Caisse DE Depot ET Placement DU Quebec, and Morgan Stanley. Company insiders that have sold Athene company stock in the last year include H Carl Mccall, John Leonard Golden, Marc J Rowan, Marc Ostryniec, Martin P Klein, and Robert L Borden.
View insider buying and selling activity for Athene or view top insider-selling stocks.

Which major investors are buying Athene stock?

ATH stock was acquired by a variety of institutional investors in the last quarter, including Brave Warrior Advisors LLC, Grantham Mayo Van Otterloo & Co. LLC, Bardin Hill Management Partners LP, UBS Group AG, Neuberger Berman Group LLC, Hsbc Holdings PLC, Alpine Associates Management Inc., and Westchester Capital Management LLC. Company insiders that have bought Athene stock in the last two years include Grant Kvalheim, James Richard Belardi, Marc A Beilinson, and Martin P Klein.
View insider buying and selling activity for Athene or or view top insider-buying stocks.

How do I buy shares of Athene?

Shares of ATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Athene's stock price today?

One share of ATH stock can currently be purchased for approximately $84.25.

How much money does Athene make?

Athene has a market capitalization of $16.19 billion and generates $14.76 billion in revenue each year. The insurance provider earns $1.54 billion in net income (profit) each year or $18.94 on an earnings per share basis.

How many employees does Athene have?

Athene employs 1,350 workers across the globe.

What is Athene's official website?

The official website for Athene is www.athene.com.

Where are Athene's headquarters?

Athene is headquartered at 96 Pitts Bay Road, Pembroke D0, HM08.

How can I contact Athene?

Athene's mailing address is 96 Pitts Bay Road, Pembroke D0, HM08. The insurance provider can be reached via phone at (441) 279-8400 or via email at [email protected].